Brief: Puma Biotechnology Q1 Adjusted EPS USD 0.1
08/05/2025 21:05
May 08 (Reuters) - Puma Biotechnology Q1 product revenue USD 43.1 million. Q1 adjusted net income USD 5 million Q1 EPS USD 0.06 Q1 net income USD 3 million
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2